nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—ABCB1—adrenal gland cancer	0.918	1	CbGaD
Carbamazepine—RALBP1—RalA downstream regulated genes—CDC42—adrenal gland cancer	0.00472	0.134	CbGpPWpGaD
Carbamazepine—CYP2C19—urine—adrenal gland cancer	0.00431	0.118	CbGeAlD
Carbamazepine—CYP1A2—urine—adrenal gland cancer	0.00352	0.0963	CbGeAlD
Carbamazepine—CYP2C9—urine—adrenal gland cancer	0.00334	0.0914	CbGeAlD
Carbamazepine—CYP3A4—urine—adrenal gland cancer	0.00255	0.0697	CbGeAlD
Carbamazepine—RALBP1—adrenal cortex—adrenal gland cancer	0.00248	0.0678	CbGeAlD
Carbamazepine—RALBP1—Regulation of CDC42 activity—CDC42—adrenal gland cancer	0.00227	0.0644	CbGpPWpGaD
Carbamazepine—UGT2B7—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00223	0.0633	CbGpPWpGaD
Carbamazepine—SCN9A—pituitary gland—adrenal gland cancer	0.00207	0.0566	CbGeAlD
Carbamazepine—RALBP1—cardiac atrium—adrenal gland cancer	0.00205	0.056	CbGeAlD
Carbamazepine—RALBP1—pituitary gland—adrenal gland cancer	0.002	0.0547	CbGeAlD
Carbamazepine—SCN9A—adrenal gland—adrenal gland cancer	0.00185	0.0505	CbGeAlD
Carbamazepine—SCN4A—pituitary gland—adrenal gland cancer	0.00185	0.0505	CbGeAlD
Carbamazepine—RALBP1—adrenal gland—adrenal gland cancer	0.00179	0.0489	CbGeAlD
Carbamazepine—ABCC2—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00177	0.0502	CbGpPWpGaD
Carbamazepine—Nepafenac—PTGS2—adrenal gland cancer	0.0017	0.163	CrCbGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—SH3KBP1—adrenal gland cancer	0.00168	0.0478	CbGpPWpGaD
Carbamazepine—Magnesium salicylate—PTGS2—adrenal gland cancer	0.00166	0.159	CrCbGaD
Carbamazepine—SCN4A—adrenal gland—adrenal gland cancer	0.00165	0.0451	CbGeAlD
Carbamazepine—SCN5A—cardiac atrium—adrenal gland cancer	0.00147	0.0401	CbGeAlD
Carbamazepine—Oxaprozin—PTGS2—adrenal gland cancer	0.00141	0.135	CrCbGaD
Carbamazepine—Salsalate—PTGS2—adrenal gland cancer	0.00141	0.135	CrCbGaD
Carbamazepine—Protriptyline—ABCB1—adrenal gland cancer	0.00122	0.117	CrCbGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—SPRY2—adrenal gland cancer	0.000992	0.0282	CbGpPWpGaD
Carbamazepine—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000967	0.0275	CbGpPWpGaD
Carbamazepine—ABCC2—adrenal gland—adrenal gland cancer	0.00096	0.0262	CbGeAlD
Carbamazepine—Epinastine—ABCB1—adrenal gland cancer	0.000903	0.0866	CrCbGaD
Carbamazepine—CYP2B6—adrenal cortex—adrenal gland cancer	0.000895	0.0244	CbGeAlD
Carbamazepine—CYP2C8—pituitary gland—adrenal gland cancer	0.000806	0.022	CbGeAlD
Carbamazepine—RALBP1—Rho GTPase cycle—CDC42—adrenal gland cancer	0.000758	0.0215	CbGpPWpGaD
Carbamazepine—CYP2B6—gonad—adrenal gland cancer	0.000741	0.0203	CbGeAlD
Carbamazepine—CYP2B6—adrenal gland—adrenal gland cancer	0.000646	0.0176	CbGeAlD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—CDC42—adrenal gland cancer	0.000588	0.0167	CbGpPWpGaD
Carbamazepine—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000583	0.0166	CbGpPWpGaD
Carbamazepine—SCN5A—Cardiac Progenitor Differentiation—IGF2—adrenal gland cancer	0.000569	0.0162	CbGpPWpGaD
Carbamazepine—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000555	0.0158	CbGpPWpGaD
Carbamazepine—Phenytoin—ABCB1—adrenal gland cancer	0.000551	0.0528	CrCbGaD
Carbamazepine—ABCC2—ABC-family proteins mediated transport—ABCB1—adrenal gland cancer	0.000531	0.0151	CbGpPWpGaD
Carbamazepine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000512	0.0145	CbGpPWpGaD
Carbamazepine—ABCB1—adrenal cortex—adrenal gland cancer	0.000478	0.0131	CbGeAlD
Carbamazepine—Trimipramine—ABCB1—adrenal gland cancer	0.00044	0.0422	CrCbGaD
Carbamazepine—SCN9A—Developmental Biology—NR5A1—adrenal gland cancer	0.000428	0.0121	CbGpPWpGaD
Carbamazepine—Promethazine—ABCB1—adrenal gland cancer	0.000423	0.0406	CrCbGaD
Carbamazepine—ABCB1—gonad—adrenal gland cancer	0.000396	0.0108	CbGeAlD
Carbamazepine—SCN4A—Developmental Biology—NR5A1—adrenal gland cancer	0.000393	0.0112	CbGpPWpGaD
Carbamazepine—ABCB1—pituitary gland—adrenal gland cancer	0.000386	0.0106	CbGeAlD
Carbamazepine—Desipramine—ABCB1—adrenal gland cancer	0.000385	0.0369	CrCbGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—BRAF—adrenal gland cancer	0.000374	0.0106	CbGpPWpGaD
Carbamazepine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000372	0.0106	CbGpPWpGaD
Carbamazepine—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000363	0.0103	CbGpPWpGaD
Carbamazepine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000354	0.0101	CbGpPWpGaD
Carbamazepine—ABCB1—adrenal gland—adrenal gland cancer	0.000345	0.00943	CbGeAlD
Carbamazepine—Imipramine—ABCB1—adrenal gland cancer	0.000326	0.0313	CrCbGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.000294	0.00834	CbGpPWpGaD
Carbamazepine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000281	0.00798	CbGpPWpGaD
Carbamazepine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00028	0.00796	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—NR5A1—adrenal gland cancer	0.000266	0.00757	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—MED12—adrenal gland cancer	0.000257	0.0073	CbGpPWpGaD
Carbamazepine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000256	0.00728	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000247	0.00701	CbGpPWpGaD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000245	0.00696	CbGpPWpGaD
Carbamazepine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000244	0.00693	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—MED12—adrenal gland cancer	0.000236	0.00671	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000229	0.00652	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—CDC42—adrenal gland cancer	0.000223	0.00633	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000216	0.00613	CbGpPWpGaD
Carbamazepine—SCN9A—L1CAM interactions—EGFR—adrenal gland cancer	0.000214	0.00609	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	0.000214	0.00608	CbGpPWpGaD
Carbamazepine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000209	0.00593	CbGpPWpGaD
Carbamazepine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000208	0.00592	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—CDC42—adrenal gland cancer	0.000205	0.00582	CbGpPWpGaD
Carbamazepine—SCN4A—L1CAM interactions—EGFR—adrenal gland cancer	0.000197	0.0056	CbGpPWpGaD
Carbamazepine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000169	0.0048	CbGpPWpGaD
Carbamazepine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000169	0.0048	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000163	0.00464	CbGpPWpGaD
Carbamazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000161	0.00457	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—MED12—adrenal gland cancer	0.00016	0.00455	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—CDC42—adrenal gland cancer	0.000159	0.00452	CbGpPWpGaD
Carbamazepine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000154	0.00438	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000152	0.00431	CbGpPWpGaD
Carbamazepine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000151	0.00428	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000148	0.0042	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—CDC42—adrenal gland cancer	0.000146	0.00415	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—CDC42—adrenal gland cancer	0.000139	0.00394	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000135	0.00384	CbGpPWpGaD
Carbamazepine—SCN5A—L1CAM interactions—EGFR—adrenal gland cancer	0.000134	0.0038	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TSHR—adrenal gland cancer	0.000132	0.00374	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000131	0.00373	CbGpPWpGaD
Carbamazepine—UGT2B7—Biological oxidations—POMC—adrenal gland cancer	0.000131	0.00373	CbGpPWpGaD
Carbamazepine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000131	0.00371	CbGpPWpGaD
Carbamazepine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000125	0.00355	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MEN1—adrenal gland cancer	0.000124	0.00352	CbGpPWpGaD
Carbamazepine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000122	0.00347	CbGpPWpGaD
Carbamazepine—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00012	0.00342	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—SDHB—adrenal gland cancer	0.000117	0.00334	CbGpPWpGaD
Carbamazepine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000117	0.00331	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000114	0.00325	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000109	0.0031	CbGpPWpGaD
Carbamazepine—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000108	0.00306	CbGpPWpGaD
Carbamazepine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000106	0.00302	CbGpPWpGaD
Carbamazepine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000106	0.00301	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—CDC42—adrenal gland cancer	9.91e-05	0.00281	CbGpPWpGaD
Carbamazepine—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	9.81e-05	0.00279	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PRKACA—adrenal gland cancer	9.46e-05	0.00269	CbGpPWpGaD
Carbamazepine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	9.45e-05	0.00268	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	9.38e-05	0.00266	CbGpPWpGaD
Carbamazepine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	9.08e-05	0.00258	CbGpPWpGaD
Carbamazepine—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	8.98e-05	0.00255	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	8.96e-05	0.00255	CbGpPWpGaD
Carbamazepine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	8.61e-05	0.00245	CbGpPWpGaD
Carbamazepine—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	8.38e-05	0.00238	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—EGFR—adrenal gland cancer	8.11e-05	0.0023	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—SDHB—adrenal gland cancer	8.03e-05	0.00228	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CDC42—adrenal gland cancer	8.02e-05	0.00228	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IGF2—adrenal gland cancer	7.73e-05	0.0022	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—GNAS—adrenal gland cancer	7.66e-05	0.00218	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—RRM1—adrenal gland cancer	7.57e-05	0.00215	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—SDHD—adrenal gland cancer	7.57e-05	0.00215	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IGF1R—adrenal gland cancer	7.48e-05	0.00212	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—EGFR—adrenal gland cancer	7.45e-05	0.00212	CbGpPWpGaD
Carbamazepine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	7.36e-05	0.00209	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—CTNNB1—adrenal gland cancer	7.3e-05	0.00207	CbGpPWpGaD
Carbamazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.01e-05	0.00199	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.97e-05	0.00198	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—CTNNB1—adrenal gland cancer	6.71e-05	0.00191	CbGpPWpGaD
Carbamazepine—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	6.64e-05	0.00189	CbGpPWpGaD
Carbamazepine—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	6.49e-05	0.00184	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TERT—adrenal gland cancer	6.43e-05	0.00183	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	6.35e-05	0.0018	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	6.35e-05	0.0018	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—SDHB—adrenal gland cancer	5.94e-05	0.00169	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—SDHB—adrenal gland cancer	5.8e-05	0.00165	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—EGFR—adrenal gland cancer	5.78e-05	0.00164	CbGpPWpGaD
Carbamazepine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.68e-05	0.00161	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.65e-05	0.00161	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—MED12—adrenal gland cancer	5.64e-05	0.0016	CbGpPWpGaD
Carbamazepine—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	5.62e-05	0.0016	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—BAD—adrenal gland cancer	5.6e-05	0.00159	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	5.54e-05	0.00158	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	5.42e-05	0.00154	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—EGFR—adrenal gland cancer	5.32e-05	0.00151	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—SDHD—adrenal gland cancer	5.17e-05	0.00147	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—RRM1—adrenal gland cancer	5.17e-05	0.00147	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—POMC—adrenal gland cancer	5.16e-05	0.00147	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—BRAF—adrenal gland cancer	5.1e-05	0.00145	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—EGFR—adrenal gland cancer	5.05e-05	0.00143	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—SDHB—adrenal gland cancer	5.03e-05	0.00143	CbGpPWpGaD
Carbamazepine—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	5.02e-05	0.00143	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	4.89e-05	0.00139	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.84e-05	0.00138	CbGpPWpGaD
Carbamazepine—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	4.58e-05	0.0013	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—CTNNB1—adrenal gland cancer	4.55e-05	0.00129	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SDHB—adrenal gland cancer	4.49e-05	0.00127	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.41e-05	0.00125	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SDHB—adrenal gland cancer	4.38e-05	0.00124	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PRKACA—adrenal gland cancer	4.12e-05	0.00117	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SDHB—adrenal gland cancer	4.09e-05	0.00116	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.96e-05	0.00112	CbGpPWpGaD
Carbamazepine—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	3.91e-05	0.00111	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—MED12—adrenal gland cancer	3.86e-05	0.0011	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—RRM1—adrenal gland cancer	3.83e-05	0.00109	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—SDHD—adrenal gland cancer	3.83e-05	0.00109	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.77e-05	0.00107	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—RRM1—adrenal gland cancer	3.74e-05	0.00106	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—SDHD—adrenal gland cancer	3.74e-05	0.00106	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CTNNB1—adrenal gland cancer	3.68e-05	0.00105	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—EGFR—adrenal gland cancer	3.6e-05	0.00102	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	3.59e-05	0.00102	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.53e-05	0.001	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SDHB—adrenal gland cancer	3.5e-05	0.000993	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GNAS—adrenal gland cancer	3.34e-05	0.000948	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.28e-05	0.000931	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ABCB1—adrenal gland cancer	3.28e-05	0.000931	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—SDHD—adrenal gland cancer	3.24e-05	0.00092	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—RRM1—adrenal gland cancer	3.24e-05	0.00092	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.22e-05	0.000915	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	3.21e-05	0.000913	CbGpPWpGaD
Carbamazepine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	3.02e-05	0.000857	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—EGFR—adrenal gland cancer	2.92e-05	0.000829	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—RRM1—adrenal gland cancer	2.89e-05	0.000822	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SDHD—adrenal gland cancer	2.89e-05	0.000822	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—MED12—adrenal gland cancer	2.85e-05	0.000811	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SDHD—adrenal gland cancer	2.82e-05	0.000802	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—RRM1—adrenal gland cancer	2.82e-05	0.000802	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	2.81e-05	0.0008	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—MED12—adrenal gland cancer	2.79e-05	0.000792	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.75e-05	0.000782	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.7e-05	0.000767	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.66e-05	0.000755	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—RRM1—adrenal gland cancer	2.64e-05	0.000749	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SDHD—adrenal gland cancer	2.64e-05	0.000749	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.55e-05	0.000724	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—adrenal gland cancer	2.45e-05	0.000696	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—MED12—adrenal gland cancer	2.42e-05	0.000686	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GNAS—adrenal gland cancer	2.28e-05	0.000648	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SDHD—adrenal gland cancer	2.25e-05	0.00064	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—RRM1—adrenal gland cancer	2.25e-05	0.00064	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—POMC—adrenal gland cancer	2.25e-05	0.000638	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	2.24e-05	0.000636	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.16e-05	0.000613	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—MED12—adrenal gland cancer	2.16e-05	0.000613	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.14e-05	0.000608	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—MED12—adrenal gland cancer	2.1e-05	0.000598	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	2.08e-05	0.000591	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	2.03e-05	0.000578	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—MED12—adrenal gland cancer	1.97e-05	0.000559	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.93e-05	0.000548	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTGS2—adrenal gland cancer	1.79e-05	0.000509	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	1.76e-05	0.000501	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.76e-05	0.000499	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.74e-05	0.000494	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.74e-05	0.000494	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.72e-05	0.000489	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GNAS—adrenal gland cancer	1.69e-05	0.000479	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—MED12—adrenal gland cancer	1.68e-05	0.000477	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	1.66e-05	0.00047	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GNAS—adrenal gland cancer	1.65e-05	0.000468	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	1.62e-05	0.00046	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	1.57e-05	0.000447	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.54e-05	0.000437	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—POMC—adrenal gland cancer	1.54e-05	0.000436	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.54e-05	0.000436	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.5e-05	0.000427	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	1.43e-05	0.000407	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GNAS—adrenal gland cancer	1.43e-05	0.000406	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.4e-05	0.000398	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	1.4e-05	0.000398	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.3e-05	0.000368	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	1.27e-05	0.000362	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	1.25e-05	0.000355	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.24e-05	0.000353	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	1.23e-05	0.000348	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	1.22e-05	0.000348	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.2e-05	0.00034	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GNAS—adrenal gland cancer	1.16e-05	0.00033	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	1.14e-05	0.000324	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—POMC—adrenal gland cancer	1.14e-05	0.000323	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—POMC—adrenal gland cancer	1.11e-05	0.000315	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	9.93e-06	0.000282	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	9.75e-06	0.000277	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—POMC—adrenal gland cancer	9.62e-06	0.000273	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	9.46e-06	0.000269	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	9.06e-06	0.000257	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	8.85e-06	0.000252	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—POMC—adrenal gland cancer	8.58e-06	0.000244	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—POMC—adrenal gland cancer	8.38e-06	0.000238	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—POMC—adrenal gland cancer	7.83e-06	0.000222	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	7.67e-06	0.000218	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	7.67e-06	0.000218	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	7.52e-06	0.000214	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	6.85e-06	0.000195	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—POMC—adrenal gland cancer	6.69e-06	0.00019	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	6.68e-06	0.00019	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	6.24e-06	0.000177	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	5.33e-06	0.000152	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—POMC—adrenal gland cancer	5.16e-06	0.000147	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	4.12e-06	0.000117	CbGpPWpGaD
